Bursts of euphoric trading are often bullish for near-term returns, but rapid surges in speculation also raise the risk of a ...

Inside the financial sector, the iShares U.S. Broker-Dealer & Securities Exchanges exchange-traded fund is stealing the ...

The S&P 500 on Thursday registered its 15th record high of the year. The tech-heavy Nasdaq hit a new peak, too. Great news for investors. But the latest advance for equities has come with another meme ...

Perhaps that’s one reason stocks are selling off globally this morning. While most indexes in Asia and Europe remain near ...

Goldman Sachs is warning of a possible stock market correction, thanks to high risk-appetite and enthusiastic retail ...

Clients of BNY will be able to invest in money market funds whose ownership will be recorded on Goldman’s blockchain platform ...

Investing.com -- Goldman Sachs has initiated coverage on Gubra A/S with a “neutral” rating and a 12-month price target of Dkr520, representing a 23.9% upside from the current price of Dkr419.80, in a ...

The cuts had been pencilled in for September if there was any severe economic turmoil from President Trump’s tariff and trade ...

Nebius stock rallies as Goldman Sachs issues a bullish note in its favor. Analyst Alex Duval expects NBIS shares to hit $68 ...

Goldman Sachs posted the largest quarterly stock-trading bonanza in its history, as banks across Wall Street bagged fat ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...